Document Classification

Section Type: RESULTS

Text: Although LDL cholesterol and hsCRP reductions were only weakly correlated in individual patients (r values < 0. 15), we recorded a 65 % reduction in vascular events in participants allocated to rosuvastatin who achieved both LDL cholesterol less than 1. 8 mmol/L and hsCRP less than 2 mg/L (event rate 0. 38 per 100 person-years ; adjusted HR 0. 35, 95 % CI 0. 23-0. 54), versus a 33 % reduction in those who achieved one or neither target (event rate 0. 74 per 100 person-years ; HR 0. 67, 95 % CI 0. 52-0. 87) (p across treatment groups < 0. 0001).